Lumpectomy with and Without Radiation for Early-Stage Breast Cancer and DGIS

ONCOLOGY

Volumn 11, Issue 9, 1997, Pages 1361-1371

  Marks, Lawrence B ^a   Prosnitz, Leonard R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; AGED; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MIDDLE AGED; PAGET NIPPLE DISEASE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEGMENTAL MASTECTOMY;

AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 0031230844     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. National Institute of Health Consensus Development Panel: Treatments of early stage breast cancer. Monogr Natl Cancer Inst 11:1, 1992.
2. Fisher B, Anderson S, Redmon CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456, 1995.
3. Fisher B, Anderson S: Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg 18:63, 1994.
4. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trail comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822, 1989.
5. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665, 1985.
6. Harris JR, Morrow M: Treatment of Early-Stage Breast Cancer in Harris JR, Lippman ME, Morrow M, Hellman S (eds): Diseases of the Breast, p 487. Philadelphia, Lippincott-Raven, 1996.
7. Fisher E, Sass R. Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). I. Intraductal carcinoma (DCIS). Cancer 57:197, 1986.
8. Fisher ER, Leeing R, Anderson S, et al: Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 47:139, 1991.
9. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754, 1996.
10. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breasi cancer. N Engl J Med 328:1581, 1993.
11. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer 75:1310, 1995.
12. Fisher ER, Costantino J, Fisher B, et al: Response - blunting the counterpoint (editorial/ reply). Cancer 75:1223, 1995.
13. Amesson L-G, Smeds S, Fagerberg G, et al: Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br J Surg 76:672, 1989.
14. Warneck J, Grossklaus D, Davis J, et al: Influence of local treatment on the recurrence rate of ductal carcoma in situ. J Am Coll Surg 180:683, 1995.
15. Schwartz GF, Finkel GC, Carcia JC, et al: Subclinical ductal carcinoma in situ of the breast - treatment by local excision and surveillance alone. Cancer 70:2468, 1992.
16. Schwartz GF: The role of excision and surveillance alone in Subclinical DCIS of the breast. Oncology 8:21, 1994.
17. Lagios MD, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ. Cancer 63:618, 1989
18. Lagios MD: Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment. Breast J 2:68, 1995.
19. Silverstein MJ, Poller DM, Waisman JR, et al: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154, 1995.
20. Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267, 1996.
21. Hetelekidis S, Silber B, Nixon AJ, et al: Is wide excision alone adequate treatment for selected patients with DCIS? Int J Radiat Oncol Biol Phys 32(suppl 1):263, 1995.
22. Carpenter R, Boulter PS, Cookt T, et al: Management of screen detected ductal carcinoma in situ of the female breast Br J Surg 76:564, 1989.
23. Gallagher WJ, Koerner FC, Wood WC: Treatment of intraductal carcinoma with limited surgery: Long-term follow-up. J Clin Oncol 7:376, 1989.
24. Page DL, Dupont WD, Rogers LW: Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 49:751, 1982.
25. Ottesen GL, Graversen HP, Blichert-Toft M, et al: Ductal carcinoma in situ of the female breast. Am J Surg Path 16:1183, 1992.
26. Bellamy COC, McDonald C, Salter DM, et al: Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Hum Pathol 24:16, 1993.
27. Liljegren G, Holmber L, Adami H-O, et al. Sector resection with or without radiotherapy for stage I breast cancer: Five-year results of a randomized trial. J Natl Cancer Inst 86:717, 1994.
28. Uppsala-Örebro Breast Cancer Study Group: Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Natl Cancer Inst 82:277, 1990.
29. Clark RM, McCulloch PB, Levine MN, et al: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683, 1992.
30. Whelan T, Clark R, Roberts R, et al: Ipsi-lateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. Int J Radiat Oncol Biol Phys 30:11, 1994.
31. Veronesi U, Luim A, del Vecchio M, et al: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587, 1993.
32. Veronesi U, Luini A, Gahmberti V, et al: Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials. World J Surg 18:70, 1994.
33. Forest AP, Stewart HJ, Everington D: Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348:708-713, 1996.
34. Sauer R, Tulusan AH, Lang N, Dunst J. Can breast irradiation be omitted in low-risk breast cancer patients after segmentectomy? First results of the Erlangen protocol. Int J Radiat Oncol Biol Phys 27 S1:146, 1993
35. Schnitt SJ, Hayman J. Gelman R, et al: A prospective study of conservative surgery alone in the treatment of selected patients with stage-I breast cancer. Cancer 77:1094, 1996.
36. Cady B, Stone MD, Wayne J: New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218:338, 1993.
37. Cady B, Stone MD, Schuler JG, et al: The new era in breast cancer. Arch Surg 131:301, 1996.
38. Moffat FL, Ketcham AS, Robinson DS, et al: Segmental mastectomy without radiotherapy for T1 and small T2 breast carcinomas. Arch Surg 125:364, 1990.
39. Moffat FL, Ketcham AS: Breast-conserving surgery and selective adjuvant radiation therapy for stage I and II breast cancer. Semin Surg Oncol 8:172, 1992.
40. Hermann RE, Esselstyn CB, Grundfest-Broniatowski S, et al: Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breast. Surg Gynecol Obslet 177:247, 1993.
41. Cooke AL, Perera F, Fisher B, et al: Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes. Int J Radiat Oncol Biol Phys 31:777, 1995.
42. Nemoto T, Patel JK, Rosner D, et al: Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67:2079, 1991.
43. Von Rueden DG, Sessions SC: Alternative therapy for elderly patients with breast cancer. Am Surg 60:72, 1994.
44. Gazet J-C, Ford HT, Coombes RC, et al: Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20:207, 1994.
45. Bates T, Riley DL, Houghton J, et al: Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. Br J Surg 18:591, 1991.
46. Kantorowitz DA, Poulter CA, Sischy B, et al: Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy Int J Radiat Oncol Biol Phys 15:263, 1988.
47. Reed MWR, Morrison JM: Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast. Br J Surg 76:898, 1989.
48. Lee KS, Plowman PN, Gilmore OJA, et al. Breast conservation therapy. How safe is post-operative tamoxifen - only in the elderly and frail? J Clin Oncol 11:50, 1992.
49. Lee KS, Plowman PN, Gilmore OJA: Tamoxifen in breast conservation therapy. Int J Clin Pharmacol Ther 33:281, 1995.
50. Morrow M: A 47-year-old woman with ductal carcinoma in situ. JAMA 275:61, 1996.
51. Morrow M, Schnitt SJ, Harris JR: In situ carcinomas, in Harris JR, Lippman ME, Morrow M, Hellman S, (eds): Diseases of the Breast, p 355. Philadelphia, Lippincott-Raven, 1996.
52. Page DL, Lagios MD: Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial (editorial). Cancer 75:1219, 1995.
53. Schnitt SJ, Harris J, Smith BL: Developing a prognostic index for ductal carcinoma in situ of the breast (editorial). Cancer 77:2189, 1996.
54. Morrow M: Breast disease in elderly women. Surg Clin North Am 74:145, 1994.
55. Fowble B: An assessment of treatment options for breast conservation in the elderly woman with early stage breast cancer (editorial). Int J Radiat Oncol Biol Phys 31:1015, 1995.
56. Martin LM, le Pechoux C, Calitchi E, et al: Management of breast cancer in the elderly. Eur J Cancer 30A:590, 1994.
57. Swain SM: Ductal carcinoma in situ. Cancer Invest 10:443, 1992.
58. Toonkel LM, Fix I, Jacobson LH, et al: Management of elderly patients with primary breast cancer. Int J Radiat Oncol Biol Phys 14:677, 1988.
59. Lindsey AM, Larson PJ, Dodd MJ, et al: Comorbidity, nutritional intake, social support, weight, and functional status over time in older patients receiving radiotherapy. Cancer Nurs 17:113, 1994.
60. National Center for Health Statistics: Vital Statistics of the United States, 1990, vol II, section 6 life tables. Washington, Public Health Service, 1994.
61. National Center for Health Statistics: Vital Statistics of the United States, Annual, statistical abstract of the Us, pp 92-93. Washington, Public Health Service, 1993
62. Simon R: Design and conduct of clinical trials, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 4th ed, p 418. Philadelphia. JB Lippincott 1993.
63. Arriagada R, Rutqvist LE, Mattsson A, et al. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13:2869, 1995.
64. Ghossein NA, Vilcoq J, Stacey P, et al : Is it necessary to irradiate the breast after conservative surgery for localized cancer? Arch Surg 122:913, 1987.
65. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52, 1996.
66. Kemperman H, Borger J, Hart A, et al: Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer: The role of local recurrence. Eur J Cancer 31A:690, 1995.
67. Veronesi U, Mrubini E, DelVecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments. Partly independent events. J Natl Cancer Inst 87:19, 1995.
68. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 333:1444, 1995.